Fortress Biotech, Inc.
FBIO
$2.76
$0.072.60%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.99M | -14.73M | -41.16M | -46.00M | -48.51M |
| Total Depreciation and Amortization | 4.63M | 4.43M | 4.46M | 4.46M | 4.53M |
| Total Amortization of Deferred Charges | 1.37M | 1.44M | 1.74M | 2.05M | 2.26M |
| Total Other Non-Cash Items | -56.10M | -50.16M | -22.64M | -32.59M | -39.95M |
| Change in Net Operating Assets | -20.02M | -21.07M | -16.77M | -8.13M | -20.55M |
| Cash from Operations | -66.14M | -80.09M | -74.37M | -80.19M | -102.22M |
| Capital Expenditure | -- | -- | -- | -- | -28.00K |
| Sale of Property, Plant, and Equipment | 1.17M | 1.17M | 1.17M | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 8.96M | 6.09M | -- | -- | -- |
| Other Investing Activities | -15.00M | -15.00M | -15.00M | -15.00M | -35.00K |
| Cash from Investing | -4.88M | -7.75M | -13.84M | -15.00M | -63.00K |
| Total Debt Issued | 5.00M | 38.67M | 43.67M | 43.67M | 53.20M |
| Total Debt Repaid | -1.38M | -1.88M | -1.88M | -1.25M | -534.00K |
| Issuance of Common Stock | 4.22M | 10.47M | 12.17M | 22.23M | 30.85M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -265.00K | -265.00K | -150.00K | -- | -400.00K |
| Total Dividends Paid | 0.00 | 0.00 | -2.01M | -4.02M | -6.02M |
| Other Financing Activities | 89.96M | 38.18M | 43.11M | 10.01M | 11.37M |
| Cash from Financing | 97.54M | 85.18M | 94.92M | 70.64M | 88.45M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26.52M | -2.66M | 6.72M | -24.55M | -13.83M |